National Agency for Food and Drug Administration and Control (NAFDAC) has raised fresh alarm over the circulation of counterfeit Dostinex (0.5mg) tablets in Nigeria, warning that unsuspecting patients could be exposed to serious health risks.
This was contained in a statement made available to Newsmen on Monday by the agency.
NAFDAC cautioned healthcare providers, pharmacists and the general public about the falsification and illegal parallel importation of three batches of the drug, which is registered under Pfizer Nigeria Ltd.
According to NAFDAC, Pfizer Nigeria Ltd, the Marketing Authorisation Holder of the product, confirmed that although Dostinex 0.5mg tablets are duly registered in Nigeria, the genuine product has not yet been officially imported into the country. This means any version currently being sold in the market is either falsified or illegally brought in.
Dostinex (cabergoline) is commonly prescribed to reduce excess prolactin levels in the body, a condition that can cause infertility, irregular menstruation, and other hormonal complications.
Health experts warn that substandard or fake versions of such medication can lead to treatment failure, worsening medical conditions, or dangerous side effects.
NAFDAC stressed that falsified, unlicensed and unregistered medicines pose significant threats to public health because their quality, safety and effectiveness cannot be guaranteed. The agency urged distributors, pharmacies and hospitals to immediately stop the sale and use of the affected product and report any suspected stock to the nearest NAFDAC office.
The regulator also advised patients currently using Dostinex to verify the source of their medication and consult their healthcare providers if they have concerns.
.
